Agilent Technologies to Acquire Proscia in All-Cash Deal

08:30 AM EDT, 10/13/2026 (MT Newswires) -- Agilent Technologies (A) agreed to acquire digital pathology software company Proscia for $240 million upfront, with an additional $30 million payable if future performance targets are met, the company said Tuesday. Proscia's digital pathology platform integrates imaging, lab systems and AI tools and serves more than 4,000 laboratories, hospitals and clinics and 16 of the top 20 pharmaceutical companies, generating more than $18 million in trailing 12-month revenue, the company said. Agilent said the deal will expand its pathology portfolio, enhance AI-driven precision medicine and diagnostics offerings, and add recurring software revenue. The deal remains subject to customary closing conditions and is expected to close early in fiscal 2027, the company added.